Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000248

Drug Information
NameSalbutamol
Synonymsm-Xylene-alpha,alpha'-diol, alpha-((tert-butylamino)methyl)-4-hydroxy-; dl-Salbutamol; L000531; Salbuven; CHEBI:2549; alpha(sup 1)-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol; Albuterol (USP); (alpha1-((tert-butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha-diol); Salbutamolum [INN-Latin]; AH 3365; MLS000758199; Ventolin Rotacaps; albuterol; Alti-Salbutamol; Albuterol [USAN]; Salbulin; Ventamol; Salbetol; Prestwick_665; R,S-Albuterol; nchembio801-comp4; KBio1_000943; PDSP1_000623; UNII-QF8SVZ843E; Respolin; 4-[2-(tert-Butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol; Salmaplon; DL-N-tert-Butyl-2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethylamine; Butotal; NCGC00015955-10; Ventoline; KBio2_005816; Salbutamol; to_000081; Salbron; AC1Q1MO0; Proventil HFA; Rotahaler; Salbutan; Novosalmol; Gerivent; NCGC00024698-04; Ecovent; Salamol; Mozal; LS-7693; BRD-A88254928-001-04-6; Prestwick3_000198; Volma; Buto-Asma; Asmaven; Salbusian; Salbutine; AB00052154; HMS2089I19; SBB066105; Vencronyl; Asthalin; Grafalin; SGCUT00011; alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha -diol; DivK1c_000943; racemic-Salbutamol; PDSP2_000620; KBio2_003248; Spectrum2_001350; IDI1_000943; Parasma; Albuterol hemisulfate; Salbutamol Sulphate; Prestwick1_000198; HSDB 7206; Salvent; Salbutamolum; Albuterol Sulphate; (+-)-Albuterol; Sultanol N; Salbutamol sulfate; Prestwick0_000198; HMS2092I08; Pneumolat; Dilatamol; Sabutal; NCGC00024698-06; NINDS_000943; Lopac0_001098; NCGC00024698-02; Proventil Inhaler; BSPBio_000155; Bio1_000935; Ventalin inhaler; 1-(tert-Butylaminomethyl)-4-hydroxy-m-xylene-alpha1,alpha3-diol; DB01001; Salbutalan; NCGC00024698-05; Servitamol; Aerolin; HMS1568H17; Cobutolin; Bio1_000446; KBio2_000680; Asmasal; Prestwick2_000198; HMS1921C04; Saventol; NCGC00015955-04; Salomol; BCBcMAP01_000116; Farcolin; SMP1_000268; Libretin; Proventil; Anebron; SPBio_002076; 4-Hydroxy-3-hydroxymethyl-alpha-((tert-butylamino)methyl)benzyl alcohol; alpha'-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol; Volmax; BRN 2213614; Arubendol-Salbutamol; Cetsim; SPECTRUM1500677; m-Xylene-alpha,alpha'-diol, alpha'-((tert-butylamino)methyl)-4-hydroxy-; Salbuhexal; Buventol; Salbu-BASF; CHEMBL714; Almotex; 1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-; Sabutamol; Asmatol; Ventilan; Bio1_001424; Ventiloboi; SMR000058513; 46725_FLUKA; 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol; Asthavent; Tobybron; Salbu-Fatol; Asmadil; CID2083; S8260_SIGMA; Bronter; S 8260; 46725_RIEDEL; Spreor; 2-(tert-Butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol; NCGC00024698-07; Volare albuterol HFA; Bugonol; 4-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; Respax; Salbutol; Asmol Uni-Dose; ST024764; LS-29861; Sultanol; dl-Albuterol; I06-0331; ProAir; Salbupur; Airomir; Ventolin Inhaler; KBioGR_001294; KBioSS_000680; Spectrum5_001059; Spectrum_000200; Suxar; AC-10286; alpha-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha'-diol; Butohaler; Asmanil; Proventil (TN); Asmidon; Lopac0_001090; D02147; HMS502P05; BPBio1_000171; Broncho-Spray; Bumol; EU-0101090; NCGC00015955-11; Butovent; 1,3-Benzenedimethanol, .alpha.1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-; Volare easi-breathe; 35763-26-9; Spectrum4_000887; 1,3-Benzenedimethanol, .alpha.(1)-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-; Asmol; Zaperin; NCGC00024698-03; Theosal; Solbutamol; EINECS 242-424-0; MolPort-001-838-925; AC1L1CVO; Medolin; Ventodisks; 18559-94-9; (+-)-Salbutamol; SPBio_001539; Salbutard; Broncovaleas; Salbuvent; Butamol; Sallbupp; VU0243312-5; Suprasma
Trade NameVentolin; Aerolin; Asthalin; Proventil; ProAi
CompanyGlaxoSmithKline
IndicationAcute Asthma
[ICD9: 493   ICD10: J45]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12
,14-17H,7-8H2,1-3H3
InChIKeyNDAUXUAQIAJITI-UHFFFAOYSA-N
Canonical SMILESCC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O    
Therapeutic ClassBronchodilator Agents
CAS NumberCAS 18559-94-9
FormulaC13H21NO3
PubChem Compound IDCID 2083.
PubChem Substance IDSID 171517.
ChEBI2549;
SuperDrug ATC IDR03AC02; R03CC02
SuperDrug CAS ID018559949;
TargetBeta-2 adrenergic receptorAgonist[2]
Ref 1Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome. Expert Opin Emerg Drugs. 2007 Sep;12(3):461-77. To Reference
Ref 2Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol). CNS Drugs. 2002;16(1):1-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543